Drug · CHEMBL1098
BUPIVACAINE
7 sourcespipelines-2026-09-18-0.3.1
Cite this record
ConductScience Library. BUPIVACAINE. Drugs and targets, record CHEMBL1098. Release pipelines-2026-09-18-0.3.1, 18 Sept 2026. https://conductscience.org/library/drugs/CHEMBL1098
On this page
Drug
Names and IDs as ChEMBL gives them, through Open Targets.
- Other names
- BR-003, Bucaine, Bupivacaina, Bupivacaine liposome, LIQ-865, LIQ865, Liposomal bupivacaine, Ropivacaine hydrochloride impurity, bupivacaine-, SKY-0402, SKY0402
- ChEMBL
Targets1
The targets ChEMBL's mechanism records give for the drug, through Open Targets. A mechanism record says what the drug acts on, not how strongly.
| Target | Protein | Mechanism | Action | Gene in Genes |
|---|---|---|---|---|
| SCN4A | Sodium channel protein type 4 subunit alpha | Sodium channel protein type IV alpha subunit blocker | BLOCKER | https://conductscience.org/library/genes/6329 |
Source ChEMBL
Diseases100
The diseases Open Targets' clinical reports study the drug for, the most trial reports first. The stage is Open Targets', the highest any of its sources reports for the pair, and each row names the sources that report it.
1 to 10 of 100Source Open Targets
See all 100 diseasesTrials1,906
Trials whose record names the drug by a name ChEMBL states, posted results first, then the largest. Open Targets read each trial's text to find its drugs. 17 more rest on that reading alone and are shown because the trials' posted result groups or NLM's indexing of their papers name the drug. 95 more that Open Targets linked to it are not shown, since the release's checks do not confirm them.
| Trial | Title | Phase | Participants | Results first posted | Named as | Linked by | Source |
|---|---|---|---|---|---|---|---|
| NCT02726620 | Decision Support for Intraoperative Low Blood Pressure | 22,435 | 2019-05-16 | bupivacaine | Its name | ClinicalTrials.gov | |
| NCT00756600 | A Multi-site Randomized Controlled Trial Comparing Regional and General Anesthesia for Effects on Neurodevelopmental Outcome and Apnea in Infants | Phase 4 | 643 | 2020-04-29 | bupivacaine | Its name | ClinicalTrials.gov |
| NCT02996227 | Bilateral Transversus Abdominis Plane Block With Exparel Verus Continuous Epidural Analgesia With Bupivacaine | 514 | 2024-01-31 | bupivacaine | Its name | ClinicalTrials.gov | |
| NCT01621230 | Effects of Bupivacaine Induced Motor Blockade During the Second Stage of Labor | Phase 4 | 481 | 2020-08-24 | bupivacaine | Its name | ClinicalTrials.gov |
| NCT03237481 | Phase 3 Herniorrhaphy Study for Postoperative Analgesia (EPOCH 2) | Phase 3 | 418 | 2021-10-27 | bupivacaine | Its name | ClinicalTrials.gov |
| NCT03295721 | Bunionectomy Study for Postoperative Analgesia (EPOCH 1) | Phase 3 | 412 | 2021-10-27 | bupivacaine | Its name | ClinicalTrials.gov |
| NCT02574520 | Trial of Extended Release Bupivacaine for Pain Relief After Surgery | Phase 3 | 399 | 2021-07-13 | bupivacaine | Its name | ClinicalTrials.gov |
| NCT02111746 | PAIN - Postoperative Analgesia INvestigation | Phase 4 | 350 | 2018-10-16 | bupivacaine | Its name | ClinicalTrials.gov |
| NCT01074190 | The Effect of Neuraxial Analgesia on Maternal Breastfeeding | 345 | 2022-04-05 | bupivacaine | Its name | ClinicalTrials.gov | |
| NCT01052012 | Bupivacaine Effectiveness and Safety in SABER® Trial | Phase 3 | 331 | 2021-06-01 | bupivacaine | Its name | ClinicalTrials.gov |
1 to 10 of 1,906
See all 1,906 trialsComparisons in its trials679
Comparisons Trial comparisons calculated in the trials whose record names the drug, most participants first. A comparison in one of its trials does not always compare the drug, so read the two groups.
| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| Hypotension Decision Support vs Usual Care Group: deaths from any cause | 158 of 4,972 | 534 of 17,463 | 22,435 | NCT02726620 | Trial comparisons |
| Hypotension Decision Support vs Usual Care Group: serious adverse events | 541 of 4,972 | 1,811 of 17,463 | 22,435 | NCT02726620 | Trial comparisons |
| Hypotension Decision Support vs Usual Care Group: Incidence of a MAP < 50 mmHg for > 20 Minutes | 85 of 4,328 | 304 of 15,624 | 19,952 | NCT02726620 | Trial comparisons |
| Hypotension Decision Support vs Usual Care Group: Usage Frequency of Cardiovascular Drugs: Glycopyrrolate | 1,257 of 4,328 | 11,093 of 15,624 | 19,952 | NCT02726620 | Trial comparisons |
| Hypotension Decision Support vs Usual Care Group: Usage Frequency of Cardiovascular Drugs: Ephinephrine | 409 of 4,328 | 1,215 of 15,624 | 19,952 | NCT02726620 | Trial comparisons |
| Hypotension Decision Support vs Usual Care Group: Incidence of a MAP < 60 mmHg | 3,798 of 4,328 | 13,779 of 15,624 | 19,952 | NCT02726620 | Trial comparisons |
| Hypotension Decision Support vs Usual Care Group: Incidence of a MAP < 50 mmHg for > 10 Minutes | 326 of 4,328 | 1,159 of 15,624 | 19,952 | NCT02726620 | Trial comparisons |
| Hypotension Decision Support vs Usual Care Group: Usage Frequency of Cardiovascular Drugs: Phenylephrine | 3,685 of 4,328 | 12,211 of 15,624 | 19,952 | NCT02726620 | Trial comparisons |
| Hypotension Decision Support vs Usual Care Group: In-hospital Mortality | 137 of 4,328 | 487 of 15,624 | 19,952 | NCT02726620 | Trial comparisons |
| Hypotension Decision Support vs Usual Care Group: Incidence of a MAP < 55 mmHg | 3,045 of 4,328 | 10,991 of 15,624 | 19,952 | NCT02726620 | Trial comparisons |
1 to 10 of 679
See all 679 comparisons in its trialsPapers from its trials910
The papers the trials whose record names the drug list on ClinicalTrials.gov as their results (RESULT) or as drawn from them (DERIVED), results first, newest first.
Tests in its trials8
The tests ConductCognition runs that the trials whose record names the drug name in their registered outcomes, as ScienceGraph matched them. ConductCognition's list names the tests it runs, not every test a trial used.
| Test | Trials naming it as an outcome | As a primary outcome | Source |
|---|---|---|---|
| Clock Drawing Task | 2 | 1 | ConductCognition |
| Verbal Learning | 2 | 1 | ConductCognition |
| Digit Span Test | 1 | 1 | ConductCognition |
| Picture Naming Test | 1 | 1 | ConductCognition |
| Short Story Recall | 1 | 0 | ConductCognition |
| Trail Making Test A | 1 | 1 | ConductCognition |
| Trail Making Test B | 1 | 1 | ConductCognition |
| Verbal Fluency | 1 | 0 | ConductCognition |
Data dates
The date of each source this release read.
Sources 7
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ConductCognition's list of its testsOur own data
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ConductCognition's list of its testsOur own data: ConductCognition's list of its tests, https://conductcognition.com
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this drug from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/drugs/v1/CHEMBL1098
GET https://conductscience.org/api/drugs/v1/CHEMBL1098/diseases?page=2